This document discusses recent scientific research into blocking DNA repair enzymes as a potential cancer therapy. It summarizes findings from a February 11, 2012 article in Science News Line. Researchers solved the structure of a DNA repair enzyme called PNKP, which could be targeted to develop new cancer therapies. Blocking PNKP's repair work in cancer cells may be a way to selectively damage DNA in tumors and kill cancer cells. The goal is to find drugs that would sensitize tumors to DNA-damaging cancer therapies by inhibiting specific repair enzymes like PNKP. Targeting DNA repair pathways provides an opportunity for improved cancer treatment and reduced side effects compared to chemotherapy.